Who owns POLARYX THERAPEUTICS INC?
- Ticker: PLYX
- CUSIP Number: 73110f100
Tip: Access positions for across all investors
Analyze quarterly positions in Polaryx Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Polaryx Therapeutics stock
Who bought or sold POLARYX THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 1.7M | $4.4M | 0% | Jun 2026 |
|
| Geode Capital Management | 171k | $455k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 105k | $280k | 0% | Jun 2026 |
|
| Hrt Financial | 82k | $218k | 100% | Jun 2026 |
|
| State Street Corporation | 58k | $439k | 100% | Mar 2026 |
|
| BlackRock | 41k | $109k | 0% | Jun 2026 |
|
| Jane Street | 31k | $84k | 100% | Jun 2026 |
|
| Northern Trust | 28k | $74k | 0% | Jun 2026 |
|
| Hanson McClain Advisors | 7.7k | $21k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 6.3k | $17k | 0% | Jun 2026 |
|
| Morgan Stanley | 5.5k | $42k | 100% | Mar 2026 |
|
| Tower Research Capital | 3.0k | $8.0k | 69% | Jun 2026 |
|
| UBS Group | 1.3k | $3.4k | -90% | Jun 2026 |
|
| Fortitude Family Office | 189.00 | $503.004600 | 100% | Jun 2026 |
|
Who sold out of Polaryx Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Mar 2026 | 128k | $964k |
| Bank of America Corporation | Mar 2026 | 26k | $196k |
| Goldman Sachs Group | Mar 2026 | 14k | $102k |
| Squarepoint Ops | Mar 2026 | 12k | $94k |